Almac provides services for all stages of drug development for small molecules, potent and cytotoxic compounds and peptides.
Its services include active pharmaceutical ingredient (API) supply, drug product development, stable and radiolabelling, solid state services and biocatalysis.
Almac also offers rapidd™, an integrated package that supports candidates from pre-clinical development to Phase I regulatory submission.
Almac specialises in chemical development, active pharmaceutical ingredient (API) supply for both small molecules and peptides, and biocatalysis technology.
With state-of-the-art facilities in the UK and the US, the company also offers first-in-human programmme rapidd™, which helps develop products from pre-clinical to Phase I regulatory submission stages.
API development and manufacture
Almac’s strength in API development and manufacture is proven by being the partner of choice for many pharmaceutical and biotechnology companies seeking integrated drug development solutions from molecule to market.
Almac has cultivated considerable biocatalysis expertise and offers a range of services, including enzyme screening panels, process development and scale-up, fermentation and molecular biology, compound purification and metabolite synthesis.
Peptide and Protein Technology
Almac’s peptide and protein technology offering is a key component within its suite of services. It offers a complete range of peptide and protein services from catalogue products through to GMP manufacture from early phase to commercial launch.
Preformulation and Solid State Services
Through the creation of synergy between solid-state chemistry and formulation development, Almac’s experienced scientists have the ability to add great value to pre-clinical projects while decreasing timelines.
Custom Peptide Synthesis for Research Use
Almac’s custom peptide synthesis offering is based on twenty years of trading, and hundreds of man-years’ experience in the field. Almac specialises in high-quality peptides with expertise in the production of complex and long peptides.
API Development and Manufacture – Late Phase
Almac has an established reputation for developing processes for the late clinical stage. Extensive experience has been established in taking processes from inception through to process validation, both in small molecule chemistry and peptides.